Your browser doesn't support javascript.
loading
Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
Yu, Lianghe; Shen, Ningjia; Shi, Yan; Shi, Xintong; Fu, Xiaohui; Li, Shuang; Zhu, Bin; Yu, Wenlong; Zhang, Yongjie.
Afiliação
  • Yu L; Hepatobiliary Surgery, the third affiliated hospital, Naval Military Medical University, Shanghai, China.
  • Shen N; Hepatobiliary Surgery, the third affiliated hospital, Naval Military Medical University, Shanghai, China.
  • Shi Y; Hepatobiliary Surgery, the third affiliated hospital, Naval Military Medical University, Shanghai, China.
  • Shi X; Hepatobiliary Surgery, the third affiliated hospital, Naval Military Medical University, Shanghai, China.
  • Fu X; Hepatobiliary Surgery, the third affiliated hospital, Naval Military Medical University, Shanghai, China.
  • Li S; Bioinformatics R&D Department, Hangzhou Mugu Technology Co., Ltd, Hangzhou, China.
  • Zhu B; Hepatobiliary Surgery, the third affiliated hospital, Naval Military Medical University, Shanghai, China.
  • Yu W; Hepatobiliary Surgery, the third affiliated hospital, Naval Military Medical University, Shanghai, China.
  • Zhang Y; Hepatobiliary Surgery, the third affiliated hospital, Naval Military Medical University, Shanghai, China.
Front Immunol ; 13: 1009789, 2022.
Article em En | MEDLINE | ID: mdl-36211448

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China